EP1663231A4 - Orale itraconazol-zusammensetzung, die nicht von nahrungsaufnahme beeinflusst wird, und herstellungsverfahren dafür - Google Patents

Orale itraconazol-zusammensetzung, die nicht von nahrungsaufnahme beeinflusst wird, und herstellungsverfahren dafür

Info

Publication number
EP1663231A4
EP1663231A4 EP04774524A EP04774524A EP1663231A4 EP 1663231 A4 EP1663231 A4 EP 1663231A4 EP 04774524 A EP04774524 A EP 04774524A EP 04774524 A EP04774524 A EP 04774524A EP 1663231 A4 EP1663231 A4 EP 1663231A4
Authority
EP
European Patent Office
Prior art keywords
orraconazole
affected
preparing
same
oral composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04774524A
Other languages
English (en)
French (fr)
Other versions
EP1663231A1 (de
Inventor
Jong Soo Woo
Hong Gi Yi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Original Assignee
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharmaceutical Co Ltd, Hanmi Pharmaceutical Industries Co Ltd filed Critical Hanmi Pharmaceutical Co Ltd
Priority claimed from PCT/KR2004/002264 external-priority patent/WO2005023262A1/en
Publication of EP1663231A1 publication Critical patent/EP1663231A1/de
Publication of EP1663231A4 publication Critical patent/EP1663231A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
EP04774524A 2003-09-09 2004-09-07 Orale itraconazol-zusammensetzung, die nicht von nahrungsaufnahme beeinflusst wird, und herstellungsverfahren dafür Withdrawn EP1663231A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2003-0063147A KR100529766B1 (ko) 2003-09-09 2003-09-09 음식물 섭취에 따른 영향이 적은, 이트라코나졸경구투여용 조성물 및 이의 제조 방법
PCT/KR2004/002264 WO2005023262A1 (en) 2003-09-09 2004-09-07 Oral itraconazole composition which is not affected by ingested food and process for preparing same

Publications (2)

Publication Number Publication Date
EP1663231A1 EP1663231A1 (de) 2006-06-07
EP1663231A4 true EP1663231A4 (de) 2009-04-29

Family

ID=36096818

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04774524A Withdrawn EP1663231A4 (de) 2003-09-09 2004-09-07 Orale itraconazol-zusammensetzung, die nicht von nahrungsaufnahme beeinflusst wird, und herstellungsverfahren dafür

Country Status (10)

Country Link
EP (1) EP1663231A4 (de)
JP (1) JP2007505103A (de)
KR (1) KR100529766B1 (de)
CN (1) CN100475211C (de)
AU (1) AU2004270069B2 (de)
BR (1) BRPI0414192A (de)
CA (1) CA2538019C (de)
IL (1) IL173743A (de)
MX (1) MXPA06002239A (de)
RU (1) RU2006111477A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200065093A (ko) 2012-06-21 2020-06-08 메인 파마 인터내셔널 프로프라이어터리 리미티드 이트라코나졸 조성물 및 투여형, 그리고 이것들의 사용 방법
CN104688536B (zh) * 2015-02-03 2016-06-08 常州制药厂有限公司 一种伊曲康唑制剂的制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000000179A1 (en) * 1998-06-27 2000-01-06 Won Jin Biopharma Co., Ltd. Solid dispersed preparation of poorly water-soluble drug containing oil, fatty acid or mixtures thereof
WO2000059475A1 (en) * 1999-04-06 2000-10-12 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
KR20020054573A (ko) * 2000-12-28 2002-07-08 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
KR20030000799A (ko) * 2001-06-27 2003-01-06 한미약품공업 주식회사 난용성 항진균제의 경구투여용 조성물 및 이의 제조 방법

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000000179A1 (en) * 1998-06-27 2000-01-06 Won Jin Biopharma Co., Ltd. Solid dispersed preparation of poorly water-soluble drug containing oil, fatty acid or mixtures thereof
WO2000059475A1 (en) * 1999-04-06 2000-10-12 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
KR20020054573A (ko) * 2000-12-28 2002-07-08 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
KR20030000799A (ko) * 2001-06-27 2003-01-06 한미약품공업 주식회사 난용성 항진균제의 경구투여용 조성물 및 이의 제조 방법

Also Published As

Publication number Publication date
KR20050026169A (ko) 2005-03-15
AU2004270069A1 (en) 2005-03-17
IL173743A0 (en) 2006-07-05
AU2004270069B2 (en) 2008-03-13
JP2007505103A (ja) 2007-03-08
BRPI0414192A (pt) 2006-10-31
MXPA06002239A (es) 2006-06-20
EP1663231A1 (de) 2006-06-07
CN1849123A (zh) 2006-10-18
CA2538019C (en) 2009-09-01
CN100475211C (zh) 2009-04-08
RU2006111477A (ru) 2006-08-27
KR100529766B1 (ko) 2005-11-17
CA2538019A1 (en) 2005-03-17
IL173743A (en) 2012-08-30

Similar Documents

Publication Publication Date Title
FR2836915B1 (fr) Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
HUP0400989A3 (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives, process for their preparation and pharmaceutical compositions containing them
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
FR2882554B1 (fr) Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2862647B1 (fr) Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
IL162765A (en) Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use
IL147977A0 (en) Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
FR2840302B1 (fr) Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
EP1515966A4 (de) Hydroxypyranonderivat und verfahren zu dessen herstellung
FR2833259B1 (fr) Procede de preparation de 2-arylbenzofuranes, composes intermediaires, 2-arylbenzofuranes et compositions les comprenant
FR2833596B1 (fr) Procede de preparation de derives d'echinocandine
FR2842525B1 (fr) Derives de 3-guanidinocarbonyl-1-heteroaryl-indole, procede de preparation a titre de medicaments et compositions pharmaceutiques les renfermant
IL172423A0 (en) Novel formulations for opioid -based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
FR2883876B1 (fr) Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1587792A4 (de) Stabiles amorphes amlodipincamsylat,verfahren zu dessen herstellung und zusammensetzung zu dessen oralerverabreichung
EP1740531A4 (de) Indenderivate und verfahren zu deren herstellung
EP1663231A4 (de) Orale itraconazol-zusammensetzung, die nicht von nahrungsaufnahme beeinflusst wird, und herstellungsverfahren dafür
DE60200023D1 (de) Isoindoloindolon-Derivate, Verfahren zu ihrer Herstellung und die enthaltende pharmazeutische Zusammensetzungen
EP1565448A4 (de) VERFAHREN ZUR HERSTELLUNG VON10H-DIBENZOçB, F] ç1,4]THIAZEPIN-11-ON
EP1551831A4 (de) Verfahren zur herstellung von risperidon
DE60200041D1 (de) Indenoindolon-Derivate, Verfahren zu ihrer Herstellung und die enthaltenden pharmazeutischen Zusammensetzungen
IL158587A0 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
HUP0303455A3 (en) Imidazolidine derivatives, their preparation and pharmaceutical compositions containing them
EP1295864A4 (de) Verfahren zur herstellung von 1,5-diaminonaphthalinen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060216

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090331

17Q First examination report despatched

Effective date: 20090715

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20101026